Lethality had a decreasing trend in 2020 (WPC = −2.99%, p < 0.05), while in 2021 it was increasing (WPC = 2.44%, p < 0.05), being stationary in 2022 (WPC = −0.02%, p > 0.05) until 2023 (WPC = 0.55%, p > 0.05).
Excerpts
However, FGF21 in the serum has highly significant positive correlation with BMI, age, TG ,antihypertensive agents use, plaque score,left cIMT, and right cIMT, respectively (all p < 0.05), but not with gender, SBP, DBP, or eGFR after adjustment for age (all p > 0.05).
Of the 10 SNP associations reported, those of rs11225308, rs363449, rs12199332 and rs17278234 remain nominally significant after this exclusion ( P < 0.05, data not shown).
On the contrary, on TNFAIP3 and CxCR4 expression, relapse had a quite significant effect (% of total variation ≥3.30, p ≤0.050), but not pregnancy (% of total variation ≤1.57, both p ≥0.6).
The indirect comparisons of efficacy between tofacitinib and control was marginally statistically significant at P < 0.05 in the NMA of all 16 trials and became significant after removing the 1 trial deemed high risk of bias.
Focusing on studies reporting between-subject correlations (619 men and 1,059 women), there was a near-significant association between the average sample age and subjective-genital agreement for men, r (20) = .42, p = .05, and a small and non-significant association for women, r (42) = .18, p = .25.
Comparisons of differing associations with risk of MI/CHD deaths and uncomplicated angina were significant for the inflammatory markers ( P < 0.05) and marginally significant for fibrin D-dimer ( P = 0.05).
borderline significancep = 0.05
A notable difference was found in the 24-hour urinary protein levels, with the median value being 300 mg/day in the lower GFR group compared to 190 mg/day in the higher GFR group, which showed borderline significance ( p = 0.05).
showed a trendp < .05
The predictive model for emotional football competence showed a trend toward statistical significance, accounting for 11% of the variance [ R = .33, R 2 = .11, F (3, 66) = 2.67, p < .05].
The LMM for the EWH-score as dependent variable revealed that a borderline significant effect for the intervention group ( P = 0.05 * ), which significantly changed across time ( P < 0.001 * ); however, the group-time interaction was statistically insignificant ( P = 0.150) (Table 4 ; Fig. 3 ).
Although the CSA of the LSR+PDRN group showed a decreasing trend, there was no significant difference in the CSA between the LSR+PDRN and LSR groups at week 6 ( P > 0.05).
The association at lag 4 days was stronger for NSTEMI (OR = 1.34, 95% CI: 1.15–1.56) than for STEMI (OR = 1.09, 95% CI: 0.93–1.27), with borderline significant difference in effect estimates ( p ‐value = 0.05; Table 3 ).
C, p < 0.05), but only showed an increasing trend in the Hip, that reached a significant level in ER ( p < 0.05).
For both the facility-based and home-based samples, there were no statistically-significant differences between control and NIVR groups for age, gender, or body mass index, although the difference between groups for BMI was close to being statistically significant (p=0.05) for the home-based sample, with the NIVR group having a larger BMI.
The association between the genotype TT and the increased cancer risk was marginally significant in Caucasians and in female subjects: OR = 3.35 [95% CI (1.01, 11.11)], P = 0.05, P heterogeneity = 0.01, and OR = 3.88 [95% CI (0.94, 16.01)], P = 0.06, P heterogeneity = 0.01, respectively (Table 1 , Figure 2 , 3 ).
Additionally, there was a borderline significant correlation between PKM2 expression and mucinous differentiation (P = 0.05).
The results of the Joinpoint regression analyses showed a decreasing trend in prevalence between 1990 and 2019 in the <5 years age group [AAPC: −0.29% (95% CI: −0.32% to −0.25%), p < 0.05], with the most pronounced decrease between 2006 and 2019 [APC: −0.76% (−1.00% to −0.52%), p < 0.05].
Considering TAC concentration, a significant trend to increase ( p < 0.05) was observed between animals intraperitoneally injected with saline solution and those injected with 250 μM betaine.
Two way ANOVA with repeated measures showed a significant effect of time (F = 9.49; p<0.001), a nearly significant interaction between time and drug (F = 1.49; p = 0.05), and no significant difference between the effects of E2 and G1 (F = 0.56; p = 0.65).
A clear trend to better outcome was observed in the optimal implementation group (5–6 SSC points) with mortality 32% versus the suboptimal group (< 4 points) mortality 44% (p = 0.05) without differences in APACHE II score (p = 0.58).
Across all analyses, one transcriptome-wide significant association with the CFR phenotype emerged from the AFR cohort analyses as well as one association approaching significance after Benjamini–Hochberg (false discovery rate (FDR)) correction ( P < 0.05).
Comparing bias scores across groups (see Table 4 ), analyses indicated a significant main effect of valence ( F (2,123) = 6.64, p = .0018) and group ( F (1,124) = 5.78, p = .0177) with patients showing greater bias scores than controls with a marginally significant valence by group interaction ( F (2,123) = 3.08, p = .05).
There was a marginally significant valence by group interaction ( F (2,123) = 3.08, p = 0.05).
Moreover, a decreasing trend of Verrucomicrobiota was found as the concentration increased, with significant discrepancy at high input concentration compared with the control ( p < 0.05).
This association followed a clear trend; the likelihood of treatment failure was highest in camels with multiple affections and decreased as the number of affections decreased ( p = 0.05; OR: 9.0; 95% CI: 4.3–9.94; Table 7 ).